AbbVie
ABBV
#26
Rank
S$444.99 B
Marketcap
$251.55
Share price
-7.28%
Change (1 day)
5.24%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of April 2025 : 101

According to AbbVie's latest financial reports the company has a price-to-book ratio of 6.03226.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3193.5255.34%
2023-12-3126.359.17%
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.49-98.53%๐Ÿ‡บ๐Ÿ‡ธ USA
6.88-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
47.1-53.37%๐Ÿ‡บ๐Ÿ‡ธ USA
27.4-72.91%๐Ÿ‡บ๐Ÿ‡ธ USA
7.08-93.00%๐Ÿ‡บ๐Ÿ‡ธ USA
1.09-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA
4.55-95.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.25-94.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
3.69-96.35%๐Ÿ‡บ๐Ÿ‡ธ USA